Andre van As

22 papers receiving 1.8k citations

Hit Papers

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma 2001 · 978 citations
9782001202620092017250500750

Peers

Andre van As
Comparison fields: 5 of 94
  • Immunology and Allergy 678
  • Physiology 1.7k
  • Pulmonary and Respiratory Medicine 1.3k
  • Rehabilitation 114
  • Emergency Medical Services 87
Replace Orion P. Twentyman with:
Orion P. Twentyman United Kingdom
Manlio Milanese Italy
Russell J. Hopp United States
V. GRAFF‐LONNEVIG Sweden
Hiroyuki Mochizuki Japan
Andrzej Bożek Poland
William B. Klaustermeyer United States
Joanne Clough United Kingdom
Anna Bręborowicz Poland
Alice Ho China
Andre van As relative to Orion P. Twentyman United Kingdom Orion P. Twentyman's profile →
Citations per field
00.5×10×14.3×
Orion P. Twentyman · 1×
Citations per year

Countries citing papers authored by Andre van As

Since Specialization
Citations

This map shows the geographic impact of Andre van As's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andre van As with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andre van As more than expected).

Fields of papers citing papers by Andre van As

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andre van As. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andre van As. The network helps show where Andre van As may publish in the future.

Co-authors

The 25 scholars most cited alongside Andre van As, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andre van As Line = papers co-authored together Andre van As links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
Hit paper breakdown →
2001978
2 1992290
3 1994137
4 198787
5 199467
6 199364
7 200749
8
Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis.
199148
9 198941
10 200736
11 198735
12 200629
13 199622
14 199019
15 199416
16 199413
17 199310
18 19867
19 19865
20 20112

About Andre van As

Andre van As is a scholar working on Immunology and Allergy, Physiology, Pulmonary and Respiratory Medicine, Animal Science and Zoology and Rehabilitation, having authored 22 papers that have together received 2.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (8 papers), Allergic Rhinitis and Sensitization (7 papers), Inhalation and Respiratory Drug Delivery (5 papers), Pharmacological Effects and Assays (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Exercise and Physiological Responses (2 papers) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Immunology and Allergy (678 citations), Physiology (1.7k citations), Pulmonary and Respiratory Medicine (1.3k citations), Rehabilitation (114 citations) and Emergency Medical Services (87 citations). Andre van As has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include William W. Busse, Giovanni Della Cioppa, Bobby Q. Lanier, Angel FowlerTaylor, Niroo Gupta, Jonathan Corren, Robert J. Dockhorn, Paul Chervinsky, James P. Kemp and Jay Grossman. Their work appears in journals such as Journal of Allergy and Clinical Immunology, CHEST Journal, European Respiratory Journal, Advances in experimental medicine and biology and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026